Stryker Corporation
NYSE: SYK · HEALTHCARE · MEDICAL DEVICES
Updated 2026-06-12
Stryker Corporation (SYK) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $5.41B | $777.70M | 64.99% | 20.85% | 14.39% |
| 2007 | $6.00B | $1.02B | 68.23% | 22.12% | 16.96% |
| 2008 | $6.72B | $1.15B | 67.68% | 23.13% | 17.08% |
| 2009 | $6.72B | $1.11B | 66.99% | 25.64% | 16.47% |
| 2010 | $7.32B | $1.27B | 67.98% | 25.28% | 17.40% |
| 2011 | $8.31B | $1.34B | 66.41% | 23.73% | 16.19% |
| 2012 | $8.66B | $1.30B | 66.72% | 22.14% | 14.99% |
| 2013 | $9.02B | $1.01B | 65.88% | 23.27% | 11.15% |
| 2014 | $9.68B | $515.00M | 64.32% | 23.04% | 5.32% |
| 2015 | $9.95B | $1.44B | 64.22% | 22.64% | 14.47% |
| 2016 | $11.32B | $1.65B | 63.98% | 22.75% | 14.54% |
| 2017 | $12.44B | $1.02B | 63.51% | 22.24% | 8.20% |
| 2018 | $13.60B | $3.55B | 63.23% | 22.82% | 26.12% |
| 2019 | $14.88B | $2.08B | 63.03% | 22.76% | 13.99% |
| 2020 | $14.35B | $1.60B | 60.99% | 21.10% | 11.14% |
| 2021 | $17.11B | $1.99B | 62.60% | 22.00% | 11.66% |
| 2022 | $18.45B | $2.36B | 59.84% | 20.24% | 12.78% |
| 2023 | $20.50B | $3.17B | 60.95% | 20.88% | 15.44% |
| 2024 | $22.59B | $2.99B | 61.87% | 22.40% | 13.25% |
| 2025 | $25.12B | $3.25B | 63.96% | 19.47% | 12.92% |
Frequently asked questions
What is Stryker Corporation's revenue?
Stryker Corporation's trailing twelve-month revenue is $25.27B, and consensus projects about $36.89B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is SYK?
In its most recent fiscal year, SYK ran a gross margin of 63.96%, an operating margin of 19.47%, and a net margin of 12.92%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does SYK generate?
SYK produced $4.28B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is SYK's balance sheet healthy?
SYK holds $4.01B in cash and equivalents against $14.86B in long-term debt, on $22.42B of shareholder equity. That debt is best read against the cash flow the business throws off each year.